In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control.

Mutant Estrogen Receptor (ERT2) ligand-binding domain fusions with Cre recombinase are a key tool for spatio-temporally controlled genetic recombination with the Cre/lox system. CreERT2 is efficiently activated in a concentration-dependent manner by the Tamoxifen metabolite trans-4-OH-Tamoxifen (tra...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anastasia Felker, Susan Nieuwenhuize, Aymeric Dolbois, Kristyna Blazkova, Christopher Hess, Larry W L Low, Sibylle Burger, Natasha Samson, Tom J Carney, Petr Bartunek, Cristina Nevado, Christian Mosimann
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2016-01-01
Colecção:	PLoS ONE
Acesso em linha:	http://europepmc.org/articles/PMC4831813?pdf=render
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!